E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers V > Headlines for ViroPharma Inc. > News item
Published on 10/22/2008 in the Prospect News Special Situations Daily.

Baker Brothers raise stake in ViroPharma

By E. Janene Geiss

Philadelphia, Oct. 22 - Baker Brothers Life Sciences Capital increased its holdings to 9.8% from 8.4% in ViroPharma, Inc. as of Oct. 21, according to an SC 13G/A filing with the Securities and Exchange Commission.

Felix and Julian Baker reported holdings of 7,567,510 shares. They previously reported an investment of 5,831,462 shares on Dec. 31, 2006 in an earlier SC 13G/A filing.

Prior to that amendment, Baker Brothers reported a 14.4% stake in the company on Jan. 26, 2005, representing 4,490,111 shares.

ViroPharma is an Exton, Pa., biotech company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.